• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Sacroiliitis Market

    ID: MRFR/Pharma/4829-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Sacroiliitis Market Research Report By Treatment Type (Medication, Physical Therapy, Surgery, Lifestyle Modification), By Diagnosis Method (Imaging Studies, Physical Examination, Laboratory Tests), By End User (Hospitals, Clinics, Rehabilitation Centers), By Disease Severity (Acute, Chronic, Recurrent) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Sacroiliitis Market Infographic
    Purchase Options

    Sacroiliitis Market Summary

    The Global MRI Systems Devices Market is projected to maintain a steady valuation of 6.52 USD Billion from 2024 to 2035.

    Key Market Trends & Highlights

    MRI Systems Devices Key Trends and Highlights

    • The market is expected to remain stable at a valuation of 6.52 USD Billion throughout the forecast period.
    • The compound annual growth rate (CAGR) for the market from 2025 to 2035 is projected to be 0.0%.
    • Despite the lack of growth, the market continues to attract interest due to advancements in imaging technology.
    • Growing adoption of MRI systems due to increasing demand for non-invasive diagnostic procedures is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.52 (USD Billion)
    2035 Market Size 6.52 (USD Billion)
    CAGR (2025-2035) 0.0%

    Major Players

    Esaote, Hologic, Bracco Imaging, KUB Technologies, Neusoft Medical Systems, United Imaging Healthcare, Canon Medical Systems, Mindray, GE Healthcare, Fujifilm Holdings, Hitachi Medical Corporation, Shenzhen Anke Hightech, Philips Healthcare, Siemens Healthineers, MR Solutions

    Sacroiliitis Market Trends

    Several significant trends are now impacting the MRI Systems Devices Market. Driven by the rising incidence of chronic illnesses and the need for precise diagnoses, one notable trend is the expanding use of sophisticated imaging technology, particularly in developing countries. Increasing healthcare costs in many nations are helping hospitals and clinics buy innovative MRI equipment, hence supporting the movement toward more common use. Key market drivers also include improved image quality and quicker scan times, which motivate operators to modernize current systems to better satisfy patient demand.

    Furthermore, the field of portable MRI equipment offers many possibilities to be investigated as they fit the growing need for point-of-care imaging solutions. Advances in technology are leading to smaller, more economical MRI equipment that will provide easier access in distant locations and enhance diagnosis in under-equipped medical institutions. Latest trends include the incorporation of artificial intelligence into MRI equipment, which seeks to simplify procedures and increase diagnostic accuracy. By means of dedicated support tools, this not only improves the quality of patient care but also helps radiologists.

    There is also a major emphasis on sustainability, which inspires companies to investigate eco-friendly materials and manufacturing techniques. As world health authorities prioritize patient experience, the movement toward patient-centric designs, which seek to improve comfort and lower anxiety during scans, is also a crucial component. Driven by innovation and changing healthcare demands, the confluence of these developments places the MRI Systems Devices Market in a position for ongoing expansion.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    The ongoing advancements in MRI technology, particularly in the areas of imaging speed and resolution, are poised to enhance diagnostic capabilities and improve patient outcomes across diverse healthcare settings.

    U.S. Food and Drug Administration (FDA)

    Sacroiliitis Market Drivers

    Aging Population

    The Global MRI Systems Devices Market Industry is influenced by the demographic shift towards an aging population, which is more susceptible to various health issues. As individuals age, the incidence of conditions requiring MRI diagnostics, such as degenerative diseases and tumors, increases. This demographic trend is prompting healthcare systems to invest in advanced imaging technologies to cater to the needs of older patients. The market's stability at 6.52 USD Billion in 2024 reflects the ongoing demand for MRI systems that can effectively address the complexities associated with aging. Consequently, the industry is likely to see sustained interest from healthcare providers aiming to improve patient outcomes.

    Market Growth Projections

    The Global MRI Systems Devices Market Industry is projected to maintain a steady trajectory, with a forecasted value of 6.52 USD Billion in 2035. Despite the anticipated CAGR of 0.0% for the period from 2025 to 2035, the market is expected to remain stable due to ongoing technological advancements and the persistent demand for MRI diagnostics. This stability may indicate a mature market, where growth is driven more by innovation and efficiency improvements rather than expansion in volume. As the industry adapts to changing healthcare needs, the focus will likely shift towards enhancing the capabilities of existing MRI systems rather than increasing the number of units sold.

    Technological Advancements

    The Global MRI Systems Devices Market Industry is experiencing a surge in technological advancements, which enhances imaging capabilities and patient outcomes. Innovations such as high-field MRI systems and functional MRI are becoming more prevalent, allowing for improved diagnostic accuracy. For instance, the introduction of 7T MRI systems is pushing the boundaries of resolution and sensitivity. These advancements not only improve clinical workflows but also expand the range of applications, from neurology to oncology. As a result, the market is poised for growth, with the industry projected to maintain a value of 6.52 USD Billion in 2024, indicating a stable demand for advanced MRI technologies.

    Government Initiatives and Funding

    The Global MRI Systems Devices Market Industry benefits from various government initiatives and funding aimed at enhancing healthcare infrastructure. Governments worldwide are increasingly recognizing the importance of advanced imaging technologies in improving diagnostic capabilities. Initiatives that promote research and development in MRI technology, along with funding for healthcare facilities to acquire modern MRI systems, are likely to bolster market growth. Such support can lead to increased accessibility and affordability of MRI services, ultimately benefiting patient care. As the market maintains a value of 6.52 USD Billion in 2024, these initiatives play a crucial role in shaping the future landscape of MRI diagnostics.

    Increasing Prevalence of Chronic Diseases

    The Global MRI Systems Devices Market Industry is significantly driven by the rising prevalence of chronic diseases, necessitating advanced diagnostic tools. Conditions such as cancer, neurological disorders, and cardiovascular diseases require precise imaging for effective treatment planning. The demand for MRI systems is likely to grow as healthcare providers seek to enhance diagnostic accuracy and patient management. With the global burden of chronic diseases expected to rise, the market is positioned to sustain its value at 6.52 USD Billion in 2024. This trend underscores the critical role of MRI technology in modern healthcare, as it provides essential insights for timely interventions.

    Rising Demand for Non-Invasive Diagnostic Techniques

    The Global MRI Systems Devices Market Industry is witnessing a growing preference for non-invasive diagnostic techniques, which MRI systems inherently provide. Patients and healthcare providers alike are increasingly favoring imaging modalities that minimize discomfort and risk. MRI's ability to produce high-resolution images without the use of ionizing radiation positions it as a preferred choice for various diagnostic applications. This trend is likely to drive the demand for MRI systems, as healthcare providers seek to offer safer alternatives for patients. The market's projected stability at 6.52 USD Billion in 2024 suggests that the shift towards non-invasive diagnostics will continue to influence purchasing decisions in the industry.

    Market Segment Insights

    MRI Systems Devices Market Application Insights

    The MRI Systems Devices Market Application segment is a vital component of the overall industry, expected to further expand as healthcare demands increase. In 2024, the Application segment will significantly contribute to the market, with Diagnostic Imaging valued at 2.5 USD Billion, showcasing its majority holding due to the increasing necessity for accurate disease diagnoses. The Functional Imaging component is projected to reach 1.5 USD Billion, playing a crucial role in assessing brain function and other physiological processes, which underlines its importance in neuroscientific research and clinical practices.

    Cardiac Imaging, valued at 1.25 USD Billion in 2024, is becoming increasingly significant given the rise in cardiovascular diseases globally, providing detailed imagery that supports timely and precise interventions. Meanwhile, Oncology Imaging, valued at 1.52 USD Billion, demonstrates its significance in oncological assessments, especially with the increasing burden of cancer cases worldwide.

    By 2035, these values are expected to grow, solidifying their importance in the healthcare sector, with Diagnostic Imaging anticipated to reach 3.75 USD Billion, Functional Imaging to 2.25 USD Billion, Cardiac Imaging to 1.8 USD Billion, and Oncology Imaging to 2.5 USD Billion. This growth trajectory illustrates the rising reliance on MRI technology across various applications, addressing crucial needs in diagnostics and treatment planning. The MRI Systems Devices Market revenue reflects an evolving landscape influenced by advancements in technology, patient needs, and a growing emphasis on preventive healthcare.

    The segment's statistics are crucial for stakeholders, providing them with necessary data to understand market trends and allocate resources effectively. Furthermore, the ongoing improvements in MRI technology, coupled with increasing adoption in emerging economies, are likely to drive innovation and enhance patient outcomes, making the Application segment a critical area of focus in the overall MRI Systems Devices Market landscape.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    MRI Systems Devices Market Type Insights

    The MRI Systems Devices Market is projected to reach a valuation of 6.77 USD Billion by 2024, enhancing its relevance in the healthcare sector. Within this market, the Type segmentation comprises Closed MRI Systems, Open MRI Systems, and Extremity MRI Systems, each contributing uniquely to the overall industry dynamics. Closed MRI Systems are known for their high-resolution imaging and are often favored in clinical practices for their reliability. Open MRI Systems provide a patient-friendly alternative, addressing fears of claustrophobia and expanding accessibility for patients unable to use traditional machines.

    Extremity MRI Systems, while less common, serve a vital role in diagnosing specific limb-related conditions, emphasizing forthright imaging for extremities without the need for full-body scans. The growing demand for diagnostic imaging, coupled with technological advancements in these systems, is propelling market growth. Furthermore, trends like personalized medicine and an increasing emphasis on non-invasive diagnostic techniques are shaping the future landscape of the MRI Systems Devices Market. However, challenges such as high costs and maintenance requirements persist alongside opportunities to innovate in imaging technology.

    As such, the market exhibits diverse potentials to cater to a wide array of healthcare needs globally.

    MRI Systems Devices Market Field Strength Insights

    The MRI Systems Devices Market is witnessing substantial growth driven by advancements in technology and increased healthcare expenditure. By 2024, the market is valued at 6.77 billion USD, with robust expansion expected to continue thereafter. Within the Field Strength category, various types of MRI systems, notably Low Field, Mid Field, and High Field MRI, play pivotal roles in diagnostics. Low Field MRI is often used in specific applications where high penetration of tissues is required and cost-effectiveness is a priority. Mid Field MRI systems provide a balanced approach, offering sufficient image clarity while being less expensive than high-end alternatives.

    High Field MRI systems dominate the market due to their exceptional detail and precision in imaging, which is critical for complex cases. The segmentation of the MRI Systems Devices Market highlights the diversity in technology, enabling tailored solutions for different clinical needs. The pressing demand for imaging systems, supported by aging populations and rising chronic diseases globally, further fuels market growth. Factors such as these underscore the importance and significance of each field strength category in enhancing patient care and diagnostic accuracy in the healthcare industry.

    MRI Systems Devices Market End User Insights

    The MRI Systems Devices Market is characterized by a robust segmentation focused on End Users, primarily comprising Hospitals, Diagnostic Imaging Centers, and Research Institutes. By 2024, the overall market is expected to be valued at 6.77 USD Billion, reflecting a steady growth trajectory fueled by increasing healthcare demands and advancements in imaging technology. Hospitals remain a crucial contributor to this market, as they account for a significant portion of MRI utilization, driven by the rising prevalence of chronic diseases requiring detailed imaging.

    Diagnostic Imaging Centers are also pivotal, providing specialized services that cater to outpatient needs and enhancing access to MRI technologies. Research Institutes play an essential role, contributing to innovation and advancements in MRI technologies, which pave the way for enhanced diagnostic capabilities. The MRI Systems Devices Market growth is bolstered by several factors, including a surge in the aging population needing imaging diagnostics and advances in MRI technologies that improve safety and effectiveness. However, challenges such as high costs and procedural complexities may hinder market expansion.

    Nevertheless, opportunities lie in expanding access to these devices and increasing awareness among healthcare professionals, ensuring that all segments are equipped to handle the growing demand for MRI diagnostic capabilities.

    Get more detailed insights about Sacroiliitis Market Research Report – Forecast to 2035

    Regional Insights

    The MRI Systems Devices Market shows a robust structure across various regions, with North America leading in market revenue, valued at 2.7 USD Billion in 2024 and projected to reach 4.05 USD Billion by 2035. This region's dominance is attributed to advanced healthcare infrastructure and significant investment in healthcare technology. Europe follows closely with a valuation of 1.8 USD Billion in 2024, rising to 2.73 USD Billion in 2035, benefiting from a strong regulatory framework and increasing healthcare expenditure.

    The APAC region accounts for 1.5 USD Billion in 2024, expected to grow to 2.25 USD Billion by 2035, driven by rising demand for medical imaging and improving healthcare access. South America, although smaller in market size with 0.53 USD Billion in 2024 and 0.79 USD Billion in 2035, is experiencing growth due to increasing health awareness and technological adoption. Meanwhile, the MEA region is valued at 0.24 USD Billion in 2024 and anticipated to reach 0.36 USD Billion by 2035, with growth influenced by investment in healthcare facilities and rising populations.

    Collectively, these regions reflect the diverse opportunities and growth trends within the MRI Systems Devices Market landscape.

    Sacroiliitis Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The MRI Systems Devices Market is characterized by a diverse array of companies that contribute to the development, manufacturing, and distribution of MRI technology, which is crucial for various medical diagnostics and research applications. As healthcare demands evolve with technological advancements, the competitive landscape in this market is becoming increasingly dynamic. Companies are focusing on innovation to enhance imaging quality, improve patient comfort, and reduce scan times, which are critical for gaining a competitive edge.

    Furthermore, the integration of artificial intelligence and machine learning into MRI systems is creating significant opportunities for businesses to differentiate themselves and capture larger market shares. The competitive insights of this market reveal a strong emphasis on strategic collaborations, research investments, and the expansion of product portfolios to address diverse healthcare requirements globally.

    Esaote

    Esaote stands out in the MRI Systems Devices Market due to its commitment to innovation and specialization. The company has established a notable presence by focusing on ultrasound and MRI solutions tailored for specific clinical applications, which positions it favorably against more generalized competitors. Esaote's strengths include its dedicated research and development efforts aimed at advancing MRI technology to improve diagnostics and treatment workflows. This focus has led to the introduction of compact and efficient MRI systems that are both cost-effective and technologically advanced.

    With a global reach, Esaote has cultivated strong relationships with healthcare providers, enhancing its distribution capabilities and reinforcing its market position.

    Hologic

    Hologic plays a significant role in the MRI Systems Devices Market by offering a broad range of diagnostic imaging solutions, particularly focusing on women's health. The company is recognized for its high-quality products and innovative technology, contributing to its strong reputation in the healthcare industry. Hologic’s MRI systems are designed to deliver precise imaging, which is critical in various clinical settings, particularly for breast imaging applications. The company's strengths lie in its research-driven approach and continuous improvements in imaging technology.

    Hologic has strategically pursued mergers and acquisitions to expand its product lineup and technological capabilities, which further solidifies its market presence. Through these initiatives, Hologic aims to improve patient outcomes and enhance operational efficiencies in healthcare settings across the globe.

    Key Companies in the Sacroiliitis Market market include

    Industry Developments

    The MRI Systems Devices Market has seen significant developments recently, with a strong focus on technological advancements and market expansion. Companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare have been enhancing their product lines with advanced imaging technologies and artificial intelligence integration. In September 2023, Fujifilm Holdings launched a new MRI system aimed at improving diagnostic capabilities in oncology, showcasing the continual innovation within the sector.

    Furthermore, in July 2023, Mindray announced an increase in its market share due to its recent focus on affordable and high-quality MRI devices, contributing to its valuation growth. Additionally, major players like United Imaging Healthcare are expanding their operations in emerging markets, significantly impacting the overall market dynamics. On the mergers and acquisitions front, Bracco Imaging was involved in an acquisition deal in August 2023 to expand its technological capabilities and product portfolio, with notable backing.

    The market is witnessing tailored solutions becoming more prevalent, reflecting the changing needs of healthcare providers worldwide, which is further accelerated by post-pandemic recovery efforts. As a result, the MRI Systems Devices Market is experiencing substantial growth, driven by innovation and strategic business maneuvers among leading companies.

    Future Outlook

    Sacroiliitis Market Future Outlook

    The MRI Systems Devices Market is projected to maintain a 0.0% CAGR from 2024 to 2035, driven by technological advancements and increasing diagnostic applications.

    New opportunities lie in:

    • Invest in AI-driven imaging solutions to enhance diagnostic accuracy.
    • Develop portable MRI systems for remote healthcare access.
    • Expand service offerings through subscription-based maintenance models.

    By 2035, the MRI Systems Devices Market is expected to stabilize, reflecting ongoing innovation and strategic adaptations.

    Market Segmentation

    MRI Systems Devices Market Type Outlook

    • Closed MRI Systems
    • Open MRI Systems
    • Extremity MRI Systems

    MRI Systems Devices Market End User Outlook

    • Hospitals
    • Diagnostic Imaging Centers
    • Research Institutes

    MRI Systems Devices Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    MRI Systems Devices Market Application Outlook

    • Diagnostic Imaging
    • Functional Imaging
    • Cardiac Imaging
    • Oncology Imaging

    MRI Systems Devices Market Field Strength Outlook

    • Low Field MRI
    • Mid Field MRI
    • High Field MRI

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 0.8(USD Billion)
    MARKET SIZE 2024 0.88(USD Billion)
    MARKET SIZE 2035 2.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 9.93% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Pfizer, Merck and Co, AbbVie, Roche, Eli Lilly, Johnson and Johnson, UCB, Teva Pharmaceutical Industries, Novartis, Celgene, Astellas Pharma, BristolMyers Squibb, GlaxoSmithKline, Amgen, Sanofi
    SEGMENTS COVERED Treatment Type, Diagnosis Method, End User, Disease Severity, Regional
    KEY MARKET OPPORTUNITIES Rising prevalence of autoimmune disorders, Advancements in diagnostic technologies, Increased awareness and education, Growth in biologic therapy options, Expanding telehealth services for management
    KEY MARKET DYNAMICS Rising prevalence of autoimmune disorders, Increasing geriatric population, Growing awareness of treatment options, Advancements in diagnostic technologies, Enhanced pharmaceutical developments
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected market size of the Global Sacroiliitis Market in 2024?

    The Global Sacroiliitis Market is expected to be valued at 0.88 billion USD in 2024.

    What will be the market valuation of the Global Sacroiliitis Market by 2035?

    By 2035, the Global Sacroiliitis Market is projected to reach a value of 2.5 billion USD.

    What is the expected CAGR for the Global Sacroiliitis Market from 2025 to 2035?

    The expected CAGR for the Global Sacroiliitis Market from 2025 to 2035 is 9.93%.

    Which region holds the largest market share for the Global Sacroiliitis Market in 2024?

    In 2024, North America holds the largest market share at 0.36 billion USD.

    What will be the market value of North America in the Global Sacroiliitis Market by 2035?

    North America is projected to reach a market value of 1.04 billion USD by 2035.

    What is the expected market size for the Medication treatment type by 2035?

    The market size for Medication treatment in the Global Sacroiliitis Market is expected to be 1.25 billion USD by 2035.

    What is the market value of Physical Therapy in the Global Sacroiliitis Market in 2024?

    The market value of Physical Therapy in 2024 is estimated to be 0.24 billion USD.

    Who are the key players in the Global Sacroiliitis Market?

    Major players include Pfizer, Merck and Co., AbbVie, Roche, and Eli Lilly.

    What is the expected value of the Surgery treatment type by 2035?

    The expected market value for the Surgery treatment type in 2035 is 0.45 billion USD.

    What is the projected market size for South America in the Global Sacroiliitis Market by 2035?

    By 2035, South America is expected to reach a market size of 0.2 billion USD.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials